insights_auto
Why is WUXIAT80 up 2.30%?
Dive Deeperchevron_right
WUXIAT80:BKK
WUXI APPTEC CO. KTB DR
THB 8.90
arrow_upward
+2.30%(+0.20) 1D
Oct 12, 4:40:00 PM GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WUXIAT80...
Open
THB 9.00
High
THB 9.00
Low
THB 8.90
Mkt. cap
567.98B
Avg. vol.
638.48K
Volume
0.00
52-wk high
THB 9.70
52-wk low
THB 3.96
Shares outstanding
561.62M
No. of employees
36K
Open
THB 9.00
High
THB 9.00
Low
THB 8.90
Mkt. cap
567.98B
Avg. vol.
638.48K
Volume
0.00
52-wk high
THB 9.70
52-wk low
THB 3.96
Shares outstanding
561.62M
No. of employees
36K
News stories
From web sources and news partners
TipRanks
·
1 day ago
WuXi AppTec Sets October Board Meeting to Approve Q3 2026 Results
Profile
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
About WUXI APPTEC CO. KTB DR
CEOSteve Yang | Ge Li
Employees35.6K
FoundedDec 1, 2000
Headquarters-
SectorHealth care
Websitewuxiapptec.com.cn